Health and Fitness Health and Fitness

Wed, March 14, 2012

[ Wed, Mar 14th 2012 ] - Market Wire

Perceptive Informatics Global Survey Results Show .. ption of Web-based RTSM Systems by Clinical Sites

Tue, March 13, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Medivation, Inc. Prices $225 Million 2.625% Convertible Senior Notes Due 2017

[ Tue, Mar 13th 2012 ] - Market Wire

Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share

[ Tue, Mar 13th 2012 ] - Market Wire

ActiveCare Acquires 4G Biometrics in Move to Addr .. ing Needs of Diabetic Patients and Their Families

[ Tue, Mar 13th 2012 ] - Market Wire

SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012

[ Tue, Mar 13th 2012 ] - Market Wire

VELscope Vx(R) Approved for Use by AppleWhite Dental Partners

[ Tue, Mar 13th 2012 ] - Market Wire

Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan

[ Tue, Mar 13th 2012 ] - Market Wire

Endo Files Amended Citizen Petition Seeking Publi .. Safety and Efficacy Issues Prior to Approval of a

[ Tue, Mar 13th 2012 ] - Market Wire

NuPathe to Report Fourth Quarter and Full Year 20 .. d Hold Conference Call on Tuesday, March 20, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Comprehensive Care Corporation Celebrates 43rd Anniversary

[ Tue, Mar 13th 2012 ] - Market Wire

Enzo Biochemas Clinical Laboratory Applies for NY .. oval for First Assay Based on Its AmpiProbea" Amp

[ Tue, Mar 13th 2012 ] - Market Wire

Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum

[ Tue, Mar 13th 2012 ] - Market Wire

Columbia Laboratories Hires Cowen and Company to .. st in Evaluating Potential Strategic Transactions

[ Tue, Mar 13th 2012 ] - Market Wire

OncoSec President and CEO Contributes to Today's Medical Developments

[ Tue, Mar 13th 2012 ] - Market Wire

Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific vor der bernahme von Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific comprar Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Acquisition de Cameron Health, Inc. par Boston Scientific

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific annuncia l'acquisizione di Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Inovio Pharmaceuticals' PENNVAX-B HIV Vaccine Dem .. ell Immune Responses in Therapeutic Vaccine Trial

[ Tue, Mar 13th 2012 ] - Market Wire

AstraZeneca Files Lawsuit against the FDA for Dec .. rding Quetiapine Product Labeling and Exclusivity

Mon, March 12, 2012

[ Mon, Mar 12th 2012 ] - Market Wire

Cannabis Science Confirms Target Indication for F .. eeting with the FDA with Its Team of FDA Speciali

[ Mon, Mar 12th 2012 ] - Market Wire

Syneron to Acquire Assets of TransPharma Medical Ltd.

[ Mon, Mar 12th 2012 ] - Market Wire

Lpath Prepares to Continue iSONEP Trials in August

[ Mon, Mar 12th 2012 ] - Market Wire

Pfizer and Bristol-Myers Squibb Look to Reshape Anticoagulant Market

[ Mon, Mar 12th 2012 ] - Market Wire

Equity Research on Mylan Inc. and Watson Pharmace .. Makers Continue to Capitalize on Expiring Patents

[ Mon, Mar 12th 2012 ] - Market Wire

American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy

[ Mon, Mar 12th 2012 ] - Market Wire

Enzon Reports Fourth-Quarter and Full-Year 2011 Results

[ Mon, Mar 12th 2012 ] - Market Wire

Valeant Pharmaceuticals Acquires a 19.9% Minority Equity Investment in Biotech Company in Brazil

[ Mon, Mar 12th 2012 ] - Market Wire

WaferGen Appoints Ivan Trifunovich President, CEO, and Director

[ Mon, Mar 12th 2012 ] - Market Wire

Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

Zynex Acquires NeuroDyne Medical, Corp.

[ Mon, Mar 12th 2012 ] - Market Wire

International Stem Cell Corporation Completes $5 .. and Elects Jim Berglund to the Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

ImmunoCellular Therapeutics Reports Manufacturing Process Data for ICT-107

[ Mon, Mar 12th 2012 ] - Market Wire

Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences

[ Mon, Mar 12th 2012 ] - Market Wire

ONSOLIS Relaunch Postponed Pending Product Modification

[ Mon, Mar 12th 2012 ] - Market Wire

Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy

[ Mon, Mar 12th 2012 ] - Market Wire

Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer

[ Mon, Mar 12th 2012 ] - Market Wire

PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting

[ Mon, Mar 12th 2012 ] - Market Wire

Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier

[ Mon, Mar 12th 2012 ] - Market Wire

Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock

Sat, March 10, 2012

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48

[ Sat, Mar 10th 2012 ] - Market Wire

I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de

[ Sat, Mar 10th 2012 ] - Market Wire

Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe

[ Sat, Mar 10th 2012 ] - Market Wire

Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede

[ Sat, Mar 10th 2012 ] - Market Wire

Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th

[ Sat, Mar 10th 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.

Fri, March 9, 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Edwards Lifesciences to Present at the 24th Annual ROTH Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi

[ Fri, Mar 09th 2012 ] - Market Wire

The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal

[ Fri, Mar 09th 2012 ] - Market Wire

Titan Medical Inc. Files Prospectus Supplement for Unit Offering

[ Fri, Mar 09th 2012 ] - Market Wire

Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Is Health Discovery Corporation Finally on the Verge of a Turnaround?

[ Fri, Mar 09th 2012 ] - Market Wire

Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin

[ Fri, Mar 09th 2012 ] - Market Wire

Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor

[ Fri, Mar 09th 2012 ] - Market Wire

(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer

[ Fri, Mar 09th 2012 ] - Market Wire

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.

[ Fri, Mar 09th 2012 ] - Market Wire

Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

BD to Present at the Barclays Capital Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down

[ Fri, Mar 09th 2012 ] - Market Wire

Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial

[ Fri, Mar 09th 2012 ] - Market Wire

Haemonetics Sets Date for Investor/Analyst Meeting

[ Fri, Mar 09th 2012 ] - Market Wire

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Delcath Selects Quintiles to Support EU Launch of CHEMOSAT

Thu, March 8, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Boston Scientific to Acquire Cameron Health, Inc.

[ Thu, Mar 08th 2012 ] - Market Wire

PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million

[ Thu, Mar 08th 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical

[ Thu, Mar 08th 2012 ] - Market Wire

Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu

[ Thu, Mar 08th 2012 ] - Market Wire

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

[ Thu, Mar 08th 2012 ] - Market Wire

LED Dental Launches Second Step Laboratory Services in Canada

[ Thu, Mar 08th 2012 ] - Market Wire

Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Mar 08th 2012 ] - Market Wire

USANA Health Sciences Unveils New Charitable Foundation

[ Thu, Mar 08th 2012 ] - Market Wire

MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb

[ Thu, Mar 08th 2012 ] - Market Wire

Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Palatin Technologies Completes Enrollment in Phas .. 2B Bremelanotide Female Sexual Dysfunction Trial

[ Thu, Mar 08th 2012 ] - Market Wire

Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1

[ Thu, Mar 08th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference

[ Thu, Mar 08th 2012 ] - Market Wire

Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports

[ Thu, Mar 08th 2012 ] - Market Wire

OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot

[ Thu, Mar 08th 2012 ] - Market Wire

Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results

[ Thu, Mar 08th 2012 ] - Market Wire

Sana Kliniken AG firma un acuerdo con Masimo para .. oluciones de supervisin de pacientes no invasivas

[ Thu, Mar 08th 2012 ] - Market Wire

Regeneron and Bayer Announce Approval of EYLEA (a .. Treatment of Wet Age-Related Macular Degeneratio

Wed, March 7, 2012

[ Wed, Mar 07th 2012 ] - Market Wire

Resmed Inc. to Present at Upcoming Conferences

[ Wed, Mar 07th 2012 ] - Market Wire

Harwood Feffer LLP Announces Investigation of Transcend Services, Inc.

[ Wed, Mar 07th 2012 ] - Market Wire

International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan

[ Wed, Mar 07th 2012 ] - Market Wire

SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease

[ Wed, Mar 07th 2012 ] - Market Wire

Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial

[ Wed, Mar 07th 2012 ] - Market Wire

Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial

[ Wed, Mar 07th 2012 ] - Market Wire

GenVec to Release Fourth Quarter and Year-End 201 .. s and Conduct a Conference Call on March 15, 2012

[ Wed, Mar 07th 2012 ] - Market Wire

EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)

[ Wed, Mar 07th 2012 ] - Market Wire

iBio to Present at the 24th Annual ROTH Conference on March 14

[ Wed, Mar 07th 2012 ] - Market Wire

Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Synthetic Biologics to Present at ROTH Annual Growth Stock Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2

[ Wed, Mar 07th 2012 ] - Market Wire

Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison

[ Wed, Mar 07th 2012 ] - Market Wire

CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS

[ Wed, Mar 07th 2012 ] - Market Wire

Solta Medical Provides Update on Liposonix Launch

[ Wed, Mar 07th 2012 ] - Market Wire

The Ensign Group Acquires an Idaho Skilled Nursing Facility

[ Wed, Mar 07th 2012 ] - Market Wire

OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i

[ Wed, Mar 07th 2012 ] - Market Wire

Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board

Tue, March 6, 2012

[ Tue, Mar 06th 2012 ] - Market Wire

Discovery Labs Announces FDA Approval of SURFAXIN .. ) for Prevention of Respiratory Distress Syndrome

[ Tue, Mar 06th 2012 ] - Market Wire

TPI Updated Corporate Presentation at 32nd Cowen's Healthcare Conference

[ Tue, Mar 06th 2012 ] - Market Wire

PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012

[ Tue, Mar 06th 2012 ] - Market Wire

ProMetic Secures a $2.5 Million Follow on Agreement

[ Tue, Mar 06th 2012 ] - Market Wire

Lpath Raises $9.3 Million in Equity Financing

[ Tue, Mar 06th 2012 ] - Market Wire

CareFusion To Acquire Pharmacy Automation Technology Leader

[ Tue, Mar 06th 2012 ] - Market Wire

STATS ChipPAC's Scalable 3D eWLB Solutions Delive .. t Advantages Over Substrate-Based Package-on-Pack

[ Tue, Mar 06th 2012 ] - Market Wire

Comprehensive Care Corporation Expands Contract with Nation's Largest Public Health Plan

[ Tue, Mar 06th 2012 ] - Market Wire

More Regulation Looms for the Medical Equipment and Supplies Industry

[ Tue, Mar 06th 2012 ] - Market Wire

Shares of Antares Pharma and Boston Scientific on .. l Equipment and Supplies Industry Soaring in 2012

[ Tue, Mar 06th 2012 ] - Market Wire

Verotoxin and E. coli 0157

[ Tue, Mar 06th 2012 ] - Market Wire

Titan Medical Inc. Announces Memorandum of Unders .. with Switzerland Based Clinique Generale-Beaulieu

[ Tue, Mar 06th 2012 ] - Market Wire

InspireMD Announces its 2011 Year End Financial Results

[ Tue, Mar 06th 2012 ] - Market Wire

Cytokinetics Announces That the European Medicine .. 57 Orphan Medicinal Product Designation for the T

[ Tue, Mar 06th 2012 ] - Market Wire

Rigel Announces Fourth Quarter and Year End 2011 Financial Results

[ Tue, Mar 06th 2012 ] - Market Wire

Shire to Initiate Two Phase 4 Clinical Trials to .. mine dimesylate) Capsules, (CII) to Concerta (met

[ Tue, Mar 06th 2012 ] - Market Wire

Implant Sciences Joins SOSSEC - Consortium of Lea .. rs in Security &;; Defense Technologies

[ Tue, Mar 06th 2012 ] - Market Wire

PAREXEL International to Present at Barclays Capital Healthcare Conference

[ Tue, Mar 06th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Oral Presenta .. 02 Clinical Study at the 2012 AACR Annual Meeting

Mon, March 5, 2012

[ Mon, Mar 05th 2012 ] - Market Wire

Cadence Pharmaceuticals to Host Conference Call a .. Quarter and Full Year 2011 Financial Results on M

[ Mon, Mar 05th 2012 ] - Market Wire

Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D

[ Mon, Mar 05th 2012 ] - Market Wire

HealthSouth to Present at the Barclays Capital Global Healthcare Conference

[ Mon, Mar 05th 2012 ] - Market Wire

Sienna Gold Warrants Extended

[ Mon, Mar 05th 2012 ] - Market Wire

Lilly Pledges $100,000 to American Red Cross' Tornado Disaster Relief Efforts

[ Mon, Mar 05th 2012 ] - Market Wire

BIOLASE Declares Stock Dividend for 2012 First Quarter

[ Mon, Mar 05th 2012 ] - Market Wire

[ Mon, Mar 05th 2012 ] - Market Wire

Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar

[ Mon, Mar 05th 2012 ] - Market Wire

New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit

[ Mon, Mar 05th 2012 ] - Market Wire

Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference

[ Mon, Mar 05th 2012 ] - Market Wire

Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med

[ Mon, Mar 05th 2012 ] - Market Wire

BioDelivery Sciences to Present at Cowen and ROTH Conferences

[ Mon, Mar 05th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference

[ Mon, Mar 05th 2012 ] - Market Wire

The Ensign Group Announces Acquisition of Doctors Express Franchise System

[ Mon, Mar 05th 2012 ] - Market Wire

OncoSec to Present at Cowen and ROTH Healthcare Conferences

[ Mon, Mar 05th 2012 ] - Market Wire

BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion

[ Mon, Mar 05th 2012 ] - Market Wire

Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi

[ Mon, Mar 05th 2012 ] - Market Wire

Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice

[ Mon, Mar 05th 2012 ] - Market Wire

diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe

Fri, March 2, 2012

[ Fri, Mar 02nd 2012 ] - Market Wire

Baxter Receives Marketing Authorization in Europe .. Union for VEPACEL Pre-Pandemic Influenza Vaccine

[ Fri, Mar 02nd 2012 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the Cowen and Co. Annual Health Care Conference

[ Fri, Mar 02nd 2012 ] - Market Wire

Cigna Corporation Announces Appearance at the Barclays Capital Global Healthcare Conference

[ Fri, Mar 02nd 2012 ] - Market Wire

Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board

[ Fri, Mar 02nd 2012 ] - Market Wire

Alere to Attend the Raymond James amp;; As .. stitutional Investors Conference on March 6, 2012

[ Fri, Mar 02nd 2012 ] - Market Wire

Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status

[ Fri, Mar 02nd 2012 ] - Market Wire

Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence

[ Fri, Mar 02nd 2012 ] - Market Wire

Syneron Closes Acquisition of Ultrashape Ltd.

[ Fri, Mar 02nd 2012 ] - Market Wire

Amerigroup Expands Operations in Texas

[ Fri, Mar 02nd 2012 ] - Market Wire

Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control

[ Fri, Mar 02nd 2012 ] - Market Wire

Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec

[ Fri, Mar 02nd 2012 ] - Market Wire

ProMetic Announces Changes to Its Board of Directors

[ Fri, Mar 02nd 2012 ] - Market Wire

Given Imaging Supports Fight Against Colorectal Cancer

[ Fri, Mar 02nd 2012 ] - Market Wire

SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial

[ Fri, Mar 02nd 2012 ] - Market Wire

Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference

[ Fri, Mar 02nd 2012 ] - Market Wire

Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress

[ Fri, Mar 02nd 2012 ] - Market Wire

IRIDEX to Present at Upcoming Investment Conferences

[ Fri, Mar 02nd 2012 ] - Market Wire

NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production

[ Fri, Mar 02nd 2012 ] - Market Wire

Concord Medical to Report Fourth Quarter and Full Year 2011 Financial Results on March 21, 2012

Thu, March 1, 2012

[ Thu, Mar 01st 2012 ] - Market Wire

Idenix Pharmaceuticals Elects Thomas Hodgson as C .. Appoints Michael Wyzga to Its Board of Directors

[ Thu, Mar 01st 2012 ] - Market Wire

IMRIS reports fourth quarter and annual 2011 financial results

[ Thu, Mar 01st 2012 ] - Market Wire

Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012

[ Thu, Mar 01st 2012 ] - Market Wire

Helix BioPharma Corp. Announces L-DOS47 Scientifi .. the Second Annual IBC Conference on Analytical Te

[ Thu, Mar 01st 2012 ] - Market Wire

Abbott to Build Nutrition Manufacturing Facility in Ohio

[ Thu, Mar 01st 2012 ] - Market Wire

Southern Home Medical Provides Corporate Overview for Shareholders and Financial Industry

[ Thu, Mar 01st 2012 ] - Market Wire

Tibet Pharmaceuticals, Inc. Announces Receipt of .. g Privatequot;; Proposal at $3.00 Per Shar

[ Thu, Mar 01st 2012 ] - Market Wire

Novelos Therapeutics and Academic Collaborators H .. pted for Presentation at 2012 AACR Annual Meeting

[ Thu, Mar 01st 2012 ] - Market Wire

Cantel Medical Corp. to Hold Conference Call to D .. lts for Its Second Quarter Ended January 31, 2012

[ Thu, Mar 01st 2012 ] - Market Wire

Boston Scientific Announces Launch of PROMUS Elementa" Platinum Chromium Stent System in Japan

[ Thu, Mar 01st 2012 ] - Market Wire

Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value

[ Thu, Mar 01st 2012 ] - Market Wire

Hamilton Thorne Expands Distribution Partnership .. e and Optical Systems Producer Leica Microsystems

[ Thu, Mar 01st 2012 ] - Market Wire

Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting

[ Thu, Mar 01st 2012 ] - Market Wire

Amica Mature Lifestyles Increases Ownership in Amica at Dundas

[ Thu, Mar 01st 2012 ] - Market Wire

Trimel Pharmaceuticals Corporation to Report Fina .. 11 and Host a Conference Call to Update Investors

[ Thu, Mar 01st 2012 ] - Market Wire

Digirad Corporation Board of Directors Adopts Strengthened Charter and Policies

[ Thu, Mar 01st 2012 ] - Market Wire

Novadaq Announces NASDAQ Listing

[ Thu, Mar 01st 2012 ] - Market Wire

Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Thu, Mar 01st 2012 ] - Market Wire

Herborium Group to Begin Commercialization of its .. roducts With Aggressive Plans to Take a Bite of a

Wed, February 29, 2012

[ Wed, Feb 29th 2012 ] - Market Wire

Elan Chairman Provides Update on CEO Succession

[ Wed, Feb 29th 2012 ] - Market Wire

CML HealthCare Completes Refinancing of Credit Facility

[ Wed, Feb 29th 2012 ] - Market Wire

Hagens Berman Continues HMA Investigation, Reminds Investors 26 Days Remain Before Deadline

[ Wed, Feb 29th 2012 ] - Market Wire

CONMED Corporation Announces Cash Dividend Policy and Declares Initial Quarterly Cash Dividend

[ Wed, Feb 29th 2012 ] - Market Wire

Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Wed, Feb 29th 2012 ] - Market Wire

Anika Therapeutics Reports 25% Increase in Fourth-Quarter Revenue

[ Wed, Feb 29th 2012 ] - Market Wire

ProPhase Labs to Release Fourth Quarter Results on Tuesday, March 6th

[ Wed, Feb 29th 2012 ] - Market Wire

Phase III studies of Jakafia" (ruxolitinib) publi .. al of Medicine Demonstrate Significant Clinical B

[ Wed, Feb 29th 2012 ] - Market Wire

Nuvo Research announces 2011 fourth quarter amp;; year-end results

[ Wed, Feb 29th 2012 ] - Market Wire

MannKind to Present at Cowen and Company 32nd Annual Health Care Conference

[ Wed, Feb 29th 2012 ] - Market Wire

MEDNAX to Present at Raymond James 33rd Annual Institutional Investors Conference in Orlando, Fla.

[ Wed, Feb 29th 2012 ] - Market Wire

Nuvo Research announces 2011 fourth quarter & year-end results

[ Wed, Feb 29th 2012 ] - Market Wire

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results

[ Wed, Feb 29th 2012 ] - Market Wire

Gilead Sciences to Present at the Cowen & Company .. nual Health Care Conference on Wednesday, March 7

[ Wed, Feb 29th 2012 ] - Market Wire

NuPathe Announces Allowance of U.S. Patent Application for NP202

[ Wed, Feb 29th 2012 ] - Market Wire

Synta to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Wed, Feb 29th 2012 ] - Market Wire

Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference

[ Wed, Feb 29th 2012 ] - Market Wire

Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences

[ Wed, Feb 29th 2012 ] - Market Wire

Amerigroup Named to 2012 quot;;Best Places to Work in Virginiaquot;; List

Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March

_{//health-fitness.news-articles.net/content/2012/ .. -two-upcoming-investor-conferences-in-march.html}
^{Published in Health and Fitness on Wednesday, March 7th 2012 at 13:17 GMT by Market Wire}

Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March -- SAN DIEGO, March 7, 2012 /PRNewswire/ --

Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March

[ ]

[ Download image ]

SAN DIEGO, March 7, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: [ HALO ]) will be presenting at the following two investor conferences in March:

24^th Annual Roth Conference in Dana Point on March 14, 2012 at 12:30 p.m. ET/9:30 a.m. PT. Kurt Gustafson, Chief Financial Officer of Halozyme Therapeutics, will provide a corporate overview.
Barclays Capital 2012 Global Healthcare Conference in Miami on March 14, 2012 at 4:15 p.m. ET/1:15 p.m. PT. Gregory I. Frost, Ph.D., President and Chief Executive Officer of Halozyme Therapeutics, will provide a corporate overview.

(Logo: [ http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ])

The presentations will be webcast through the "Investors" section of Halozyme's corporate website at [ www.halozyme.com ], and recordings will be made available for 90 days following the events. To access the live webcasts, please log on to Halozyme's website approximately fifteen minutes prior to the presentations to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at [ www.halozyme.com ].

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
[ aerickson@halozyme.com ]

SOURCE Halozyme Therapeutics, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.halozyme.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire